Per Diem Lead Dosing Session Monitor

Required

• Licensed mental health professional in Massachusetts, New York, Pennsylvania, or Texas (e.g., PsyD, PhD, LCSW, LMSW, LMHC, LMFT), with the ability to provide psychotherapy in compliance with state regulations
• Attention to detail is critical for this role to ensure accurate observation, documentation, and reporting of dosing sessions, with strict adherence to ICH-GCP standards and protocol requirements.
• Experience working with individuals with depression, anxiety, or other mood disorders
• Strong interpersonal and communication skills, with an interest in advancing mental health care in a clinical research setting.
• Ability to meet fixed scheduling expectations, including consistent on-site availability.
• Final candidate must be approved by both Adams Clinical and the study sponsor.
• This is a per diem, as-needed position, with work hours based on study enrollment, participant availability, and trial timelines.
• Therapists should anticipate approximately 2-3 days per week of direct participant-facing responsibilities. These include pre-dose preparation, real-time monitoring during psychedelic dosing sessions, and post-dose follow up sessions. The exact schedule will vary based on study volume, participant availability, and internal scheduling priorities.
• Flexibility and responsiveness to shifting scheduling needs are essential.
• A majority of the participant appointments must be conducted in person at our research site locations, and a portion can be conducted remotely by the therapist
• Therapists must be willing to learn and adhere to ICH-GCP standards.
• Additional responsibilities include administrative tasks, onboard, and study-related training, as well as other tasks assigned.